Evidence map›Paper›PMID 36614810›Full record

ArticleJournal of clinical medicine2022

Echocardiographic Evaluation in Paediatric Sickle Cell Disease Patients: A Pilot Study.

Letizia Sabatini, Marcello Chinali, Alessio Franceschini, Margherita Di Mauro, Silvio Marchesani, Francesca Fini, Giorgia Arcuri, Mariachiara Lodi, Giuseppe Palumbo, Giulia Ceglie

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Letizia SabatiniDepartment of Pediatrics, Bambino Gesù Children's Hospital-IRCCS, Piazza Sant'Onofrio 4, 00165 Rome, Italy.ORCID 0000-0002-8168-6352
Marcello ChinaliDepartment of Pediatric Cardiology and Cardiovascular Surgery, Bambino Gesù Children's Research Hospital-IRCSS, Piazza Sant'Onofrio 4, 00165 Rome, Italy.
Alessio FranceschiniDepartment of Pediatric Cardiology and Cardiovascular Surgery, Bambino Gesù Children's Research Hospital-IRCSS, Piazza Sant'Onofrio 4, 00165 Rome, Italy.ORCID 0000-0003-2339-093X
Margherita Di MauroDepartment of Pediatrics, Bambino Gesù Children's Hospital-IRCCS, Piazza Sant'Onofrio 4, 00165 Rome, Italy.
Silvio MarchesaniDepartment of Pediatrics, Bambino Gesù Children's Hospital-IRCCS, Piazza Sant'Onofrio 4, 00165 Rome, Italy.
Francesca FiniDepartment of Pediatrics, Bambino Gesù Children's Hospital-IRCCS, Piazza Sant'Onofrio 4, 00165 Rome, Italy.
Giorgia ArcuriDepartment of Systems Medicine, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.
Mariachiara LodiDepartment of Pediatric Hematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital-IRCCS, Piazza Sant'Onofrio 4, 00165 Rome, Italy.ORCID 0000-0002-4724-3347
Giuseppe PalumboDepartment of Systems Medicine, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.
Giulia CeglieDepartment of Systems Medicine, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.ORCID 0000-0002-4127-6914
University of Rome Tor Vergata · ITBambino Gesù Children's Hospital · IT

Funding

Italian ministry of health Current research fund
6 · The paper itself

Abstract

Cardiovascular involvement has a great impact on morbidity and mortality in sickle cell disease (SCD). Currently, few studies are available regarding the paediatric setting and, moreover, current guidelines for the echocardiogram screening program in the asymptomatic paediatric population are controversial. We performed a retrospective observational monocentric study on 64 SCD patients (37 male and 27 female, median age 10) at the Bambino Gesù Childrens' Hospital, who had undergone a routine transthoracic echocardiogram. In total, 46 (72%) patients had at least one cardiac abnormality. Left atrial dilatation (LAD) was present in 41 (65%) patients and left ventricular hypertrophy (LVH) was found in 29 (45%) patients. Patients with LAD showed lower median haemoglobin levels (

Indexed as

cardiovascular complicationsechocardiographypaediatric populationsickle cell disease

Identifiers

PMID36614810
PMCPMC9821745
OpenAlexW4311963183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.